Advertisement

CEN Case Reports

, Volume 7, Issue 2, pp 301–306 | Cite as

Ruptured renal artery in microscopic polyangiitis: a case report and literature review

  • Ayumi Ishiwatari
  • Mariko Endo
  • Sachiko Wakai
Case Report
  • 74 Downloads

Abstract

Medium-vessel hemorrhage is a rare occurrence in ANCA-associated vasculitis, and has been previously described in only a few patients with microscopic polyangiitis. We report a case of renal hemorrhage in a patient with microscopic polyangiitis that was successfully managed by transcatheter arterial embolization of the active bleeding sites. The early clinical findings included necrotizing arteritis, as indicated by skin biopsy; rapidly progressive glomerulonephritis; mononeuritis multiplex; positive screening for myeloperoxidase-specific antineutrophil cytoplasmic antibody. Corticosteroid therapy was initiated. The patient’s health deteriorated at 1 week, with rapidly progressing anemia. Computerized tomography identified a large, right-sided, perirenal hematoma, with active bleeding. Bleeding was successfully managed via segmental embolization of the renal artery. The patient was treated with steroid therapy and MZR, and subsequently underwent maintenance hemodialysis treatment for end-stage renal disease. Spontaneous renal hemorrhage is a rare but fatal clinical condition. A ruptured renal artery should be considered in a patient with microscopic polyangiitis, even in the absence of previous trauma and renal biopsy, when unexplained anemia or signs of shock occur.

Keywords

Antineutrophil cytoplasmic antibody (ANCA) Artery embolization Microscopic polyangiitis Perirenal hematoma Renal hemorrhage 

Notes

Acknowledgements

We gratefully acknowledge Dr. Takaaki Sakoma for histological assessment and Dr. Takayuki Hattori for angiographic management. We would like to thank Editage (http://www.editage.jp) for English language editing.

Compliance with ethical standards

Conflict of interest

The authors have declared that no conflict of interest exists.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Informed consent was obtained from the participant included in the article.

References

  1. 1.
    Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1–11.CrossRefPubMedGoogle Scholar
  2. 2.
    Baker SB, Robinson DR. Unusual renal manifestations of Wegener’s granulomatosis. Report of two cases. Am J Med. 1978;64:883–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Senf R, Jurgensen JS, Teichgraber U, Kampf D, Schindler R. Ruptured arterial aneurysm of the kidney in a patient with Wegener’s granulomatosis. Nephrol Dial Transplant. 2003;18:2671–3.CrossRefPubMedGoogle Scholar
  4. 4.
    Arlet JB, Le Thi Huong D, Marinho A, Cluzel P, Wechsler B, Piette JC. Arterial aneurysms in Wegener’s granulomatosis: case report and literature review. Semin Arthritis Rheum. 2008;37:265–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Boersma HE, Nap RH, Haanstra WP, Hooijboer PG, van der Kleij FG. A rare cause of spontaneous perirenal haemorrhage in a patient with ANCA-associated vasculitis. Neth J Med. 2013;71:318–22.PubMedGoogle Scholar
  6. 6.
    Tamei N, Sugiura H, Takei T, Itabashi M, Uchida K, Nitta K. Ruptured arterial aneurysm of the kidney in a patient with microscopic polyangiitis. Intern Med. 2008;47:521–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66:222–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009;68:1827–32.CrossRefPubMedGoogle Scholar
  9. 9.
    Guillevin L, Lhote F, Amouroux J, Gherardi R, Callard P, Casassus P. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg Strauss syndrome: indications for the classification of vasculitides of the polyarteritis nodosa group. Br J Rheumatol. 1996;35:958–64.CrossRefPubMedGoogle Scholar
  10. 10.
    Moutsopoulos HM, Avgerinos PC, Tsampoulas CG, Katsiotis PA. Selective renal angiography in Wegener’s granulomatosis. Ann Rheum Dis. 1983;42:192–5.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Carron PL, Malvezzi P, Thony F. Finding of kidney arterial aneurysms in a case of Wegener’s granulomatosis. Ther Apher Dial. 2011;15:509–10.CrossRefPubMedGoogle Scholar
  12. 12.
    Inatsu A, Shimizu J, Ooshima S, Matsukuma S, Koga K, Shiwachi S, et al. Antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis with intrarenal aneurysms and renal arteriovenous fistulaes. Intern Med. 2002;41:853–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Nuzum JW Jr. Polyarteritis nodosa: statistical review of one hundred seventy-five cases from the literature and report of a “typical case”. Arch Intern Med. 1954;94:942–55.CrossRefGoogle Scholar
  14. 14.
    Travers RL, Allison DJ, Brettle RP, Hughes G. Polyarteritis nodosa: a clinical and angiographic analysis of 17 cases. Semin Arthritis Rheum. 1979;8:184–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Mowrey FH, Lundberg EA. The clinical manifestations of essential polyarteritis nodosa (periarteritis nodosa), with emphasis on the hepatic manifestations. Ann Intern Med. 1954;40:1145–64.CrossRefPubMedGoogle Scholar
  16. 16.
    Zhang JQ, Fielding JR, Zou KH. Etiology of spontaneous perirenal hemorrhage: a meta-analysis. J Urol. 2002;167:1593–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Malek-Marín T, Arenas D, Gil T, Moledous A, Okubo M, Arenas JJ, et al. Spontaneous retroperitoneal hemorrhage in dialysis: a presentation of 5 cases and review of the literature. Clin Nephrol. 2010;74:229–44.CrossRefPubMedGoogle Scholar
  18. 18.
    Kawasaki Y. Mizoribine: a new approach in the treatment of renal disease. Clin Dev Immunol. 2009;2009:681482.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Tokunaga M, Tamura M, Kabashima N, Serino R, Shibata T, Matsumoto M, et al. A case report of steroid-resistant antineutrophil cytoplasmic antibody-related vasculitis successfully treated by mizoribine in a hemodialysis patient. Ther Apher Dial. 2009;13:77–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Hirayama K, Kobayashi M, Hashimoto Y, Usui J, Shimizu Y, Hirayama A, et al. Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis. Am J Kidney Dis. 2004;44:57–63.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2018

Authors and Affiliations

  1. 1.Department of NephrologyOkubo HospitalTokyoJapan

Personalised recommendations